This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2017 Mar;18(3):e137.

doi: 10.1016/S1470-2045(17)30080-3. Epub 2017 Feb 3.

Novel mutations in cervical cancer

Talha Khan Burki

PMID: 28163002
DOI: 10.1016/S1470-2045(17)30080-3

Novel mutations in cervical cancer

Talha Khan Burki. Lancet Oncol. 2017 Mar.

. 2017 Mar;18(3):e137.

doi: 10.1016/S1470-2045(17)30080-3. Epub 2017 Feb 3.

Author

Talha Khan Burki

PMID: 28163002
DOI: 10.1016/S1470-2045(17)30080-3

No abstract available

PubMed Disclaimer

Similar articles

Proteomics approaches in cervical cancer: focus on the discovery of biomarkers for diagnosis and drug treatment monitoring.
Kontostathi G, Zoidakis J, Anagnou NP, Pappa KI, Vlahou A, Makridakis M. Kontostathi G, et al. Expert Rev Proteomics. 2016 Aug;13(8):731-45. doi: 10.1080/14789450.2016.1210514. Expert Rev Proteomics. 2016. PMID: 27398979 Review.
Dysregulation of miRNA-21 and their potential as biomarkers for the diagnosis of cervical cancer.
Han Y, Xu GX, Lu H, Yu DH, Ren Y, Wang L, Huang XH, Hou WJ, Wei ZH, Chen YP, Cao YG, Zhang R. Han Y, et al. Int J Clin Exp Pathol. 2015 Jun 1;8(6):7131-9. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26261606 Free PMC article.
Cervical cancer: Biomarkers for diagnosis and treatment.
Dasari S, Wudayagiri R, Valluru L. Dasari S, et al. Clin Chim Acta. 2015 May 20;445:7-11. doi: 10.1016/j.cca.2015.03.005. Epub 2015 Mar 12. Clin Chim Acta. 2015. PMID: 25773118 Review.
Epidermal growth factor receptor pathway mutation and expression profiles in cervical squamous cell carcinoma: therapeutic implications.
Bumrungthai S, Munjal K, Nandekar S, Cooper K, Ekalaksananan T, Pientong C, Evans MF. Bumrungthai S, et al. J Transl Med. 2015 Jul 25;13:244. doi: 10.1186/s12967-015-0611-0. J Transl Med. 2015. PMID: 26209091 Free PMC article.
A novel biomarker for cervical cancer.
Tokino T. Tokino T. Cancer Biol Ther. 2009 Jun;8(12):1154-5. doi: 10.4161/cbt.8.12.8986. Epub 2009 Jun 12. Cancer Biol Ther. 2009. PMID: 19502775 No abstract available.

See all similar articles

Cited by

Mechanism underlying long non‑coding RNA ILF3‑AS1‑mediated inhibition of cervical cancer cell proliferation, invasion and migration, and promotion of apoptosis.
Zhu L, Chen R, Jiang C, Xie Q, Zhao W, Gao X, Huang H. Zhu L, et al. Mol Med Rep. 2021 Aug;24(2):554. doi: 10.3892/mmr.2021.12193. Epub 2021 Jun 3. Mol Med Rep. 2021. PMID: 34080029 Free PMC article.
Cervical cancer heterogeneity: a constant battle against viruses and drugs.
Sun Q, Wang L, Zhang C, Hong Z, Han Z. Sun Q, et al. Biomark Res. 2022 Nov 17;10(1):85. doi: 10.1186/s40364-022-00428-7. Biomark Res. 2022. PMID: 36397138 Free PMC article. Review.
Variants Identified in the HOXC13 and HOXD13 Genes Suggest Association with Cervical Cancer in a Cohort of Mexican Women.
Juárez-Rendón KJ, Castro-García MA, Prada-Ortega DG, Rivera G, Ruíz-Godoy LM, Enríquez-Cárcamo VI, Reyes-Lopez MA. Juárez-Rendón KJ, et al. Genes (Basel). 2023 Jan 30;14(2):358. doi: 10.3390/genes14020358. Genes (Basel). 2023. PMID: 36833285 Free PMC article.
EGR1 promotes stemness and predicts a poor outcome of uterine cervical cancer by inducing SOX9 expression.
Zhao J, Li H, Yuan M. Zhao J, et al. Genes Genomics. 2021 May;43(5):459-470. doi: 10.1007/s13258-021-01064-5. Epub 2021 Mar 9. Genes Genomics. 2021. PMID: 33687657

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical